Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Alexandra Golby, MD, principal investigator and professor of Neurosurgery and Radiology at Brigham and Women’s Hospital, discusses new imaging methods meant to reduce the complications of planning and…
In a poster presentation at ASCO 2018, authors shared data from a recent study which suggest that testing and modulating the composition of the gut microbiome can have…
In the largest prospective study of angiogenesis in metastatic renal cell carcinoma (mRCC) patients to date, an Italian study yielded data that suggests sorafenib had no meaningful impact…
Nearly 1,400 Texans died from opioid-related overdoses in 2016. It’s a growing problem across the state and country, and in response emergency physicians at Baylor University Medical Center…
Dani Baird and her family members carry a mutated Cu,Zn-superoxide dismutase-1 (SOD1) gene, one of thirteen genes suspected of causing motor neuron diseases (MNDs). According to the National…
